Global Gastric Volvulus Treatment Market Projected to Grow at 6.5% CAGR, Reaching $37.18 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Gastric Volvulus Treatment Industry Market Size Be by 2025?
The market catering to gastric volvulus treatment has experienced robust expansion lately, projected to increase its valuation from $27.36 billion in 2024 to $28.86 billion by 2025, reflecting a compound annual growth rate (CAGR) of 5.5%; this prior period's expansion stems from multiple factors including progress in surgical methodologies, better diagnostic tools, heightened awareness and patient education efforts, an increase in procedures performed using minimally invasive approaches, and ongoing scientific research and clinical investigations.

What's the Long-Term Growth Forecast for the Gastric Volvulus Treatment Market Size Through 2029?
The gastric volvulus treatment market is projected to witness strong growth in the coming years, reaching $37.18 billion by 2029 at a compound annual growth rate (CAGR) of 6.5%. The forecast period's growth can be credited to regulatory changes and approvals, advancements in surgical procedures, an increasing geriatric population, development of customized treatment plans, and the adoption of advanced imaging technologies. Key trends expected during this period include the rise of minimally invasive surgical techniques, increased awareness and early intervention, progress in treatment research, collaborative medical practices, and personalized treatment approaches.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

What Are the Key Growth Drivers Fueling the Gastric Volvulus Treatment Market Expansion?
The expanding segment of elderly individuals, defined as those aged 65 and above, is projected to be a significant catalyst for the expansion of the gastric volvulus treatment market in the future. This demographic frequently contends with diverse ailments stemming from diminished immune defenses and advancing age, and since gastric volvulus specifically manifests in people past fifty, the escalation in the count of older adults is anticipated to boost the market's trajectory. To illustrate this trend, data released in January 2024 by the Population Reference Bureau, a non-profit organization based in the US, foresees American citizens aged 65 or more increasing from 58 million in 2022 to an estimated 82 million by 2050, marking a substantial 47 percent jump, concurrently raising their share of the total populace from seventeen percent to twenty-three percent, thus confirming that the upward trend in the elderly population directly fuels the market for gastric volvulus treatments.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

What Are the Key Trends Driving Gastric Volvulus Treatment Market Growth?
A significant movement in the sphere of gastric volvulus treatment involves the ascent of novel product developments, compelling key industry participants to launch inventive offerings to uphold their market standing; for example, in October 2023, Pfizer Inc., a corporation situated in the United States, disclosed receiving authorization from the U.S. Food and Drug Administration for VELSIPITY (etrasimod), which is formulated as a sovereign, daily oral activator targeting the sphingosine-1-phosphate (S1P) receptor, intended for adults experiencing moderate to severe ongoing ulcerative colitis (UC), with the prescribed dose being 2 mg, providing these individuals an opportunity to attain steroid-free remission through a convenient, orally administered medication presenting a favorable risk-benefit assessment, an approval considered a crucial milestone for UC sufferers seeking fresh treatment modalities for their chronic ailment and prepared to commence escalated care.

How Is the Gastric Volvulus Treatment Market Segmented?
The gastric volvulus treatmentmarket covered in this report is segmented -

1) By Type: Organo-Axial Volvulus; Mesentero-Axial Volvulus
2) By Treatment Type: Medication; Surgery
3) By Route Of Administration: Oral; Parenteral
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy
5) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users

Subsegments:
1) By Organo-Axial Volvulus: Surgical Intervention; Endoscopic Management; Gastropexy; Other Treatment Methods
2) By Mesentero-Axial Volvulus: Surgical Intervention; Gastropexy; Endoscopic Techniques; Other Treatment Approaches

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9382&type=smp

Which Companies Are Leading the Charge in Gastric Volvulus Treatment Market Innovation?
Major companies operating in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc

Which Regions Are Leading the Global Gastric Volvulus Treatment Market in Revenue?
North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9382

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.